Drug therapy represents 72% of the therapy type category and atherosclerosis accounts for 76% of indication demand in 2026. The atherosclerosis market is estimated at USD 48.9 billion in 2026, is projected to reach USD 63.9 billion by 2036 and is forecast to post a 2.7% CAGR between 2026 and 2036.